Entiteit | Type entiteit | Industrie | |
---|---|---|---|
OncoSynergy, Inc.
![]() OncoSynergy, Inc. Pharmaceuticals: MajorHealth Technology OncoSynergy, Inc. engages in the provision of solutions for treatment-resistant cancer. It develops new class of oncology therapeutics, called Resistance Mechanism Inhibitors (RMIs), it is a multi-action, tumor-agnostic drug platforms that have shown preclinical promise as monotherapy and in strategic combinations. The company was founded by Shawn W. Carbonell, Anne-Marie Carbonell, and Catherine Park in 2011 and is headquartered in Greenwich, CT.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Connectie in verschillende bedrijven
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|
Internationaal
Sectoraal
Operationeel
Founder | 2 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Chief Operating Officer | 1 |
Insiders | |
---|---|
Catherine Park | 1 |
Anne-Marie Carbonell | 1 |
Ambar Picon | 1 |